Key highlights
Product specifications
| Compound Class | Synthetic Peptide · Long-acting GHRH analog (modified GRF 1-29) · GHRH Receptor Agonist |
|---|---|
| Form | Lyophilized powder in sterile glass vial |
| Quantity | 5 mg per vial |
| CAS Number | 863288-34-0 |
| Chemical Formula | C152H252N44O42 |
| Molar Mass | 3367.9 g/mol |
| Half-Life | ~6–8 days |
| Residues | 30-amino-acid analog (modified GRF[1-29] with DAC-linked lysine) |
| Amino Acid Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys |
| Synonyms | CJC-1295 DAC, CJC-1295 with DAC, DAC:GRF |
| Verified Purity | Batch-tested to 98.96% (HPLC) |
For laboratory research use only. Not for human or animal consumption.
View certificates of analysisIndependently verified
This peptide is analyzed by an accredited US third-party laboratory before it ships.
Identity and purity confirmed by MZ Biolabs (Tucson, AZ), a US DEA-licensed analytical facility, via HPLC purity analysis and mass-spectrometry identity confirmation under GLP standards.
Our third-party certificates of analysis are published on our website — no login required.
CJC-1295 DAC98.96% pure
Storage & handling
Peptides are photo- and temperature-sensitive; handle per standard laboratory practice.
- Lyophilized storage: Keep the sealed vial cool, dry, and protected from light. For longer-term storage, freezing is standard practice for lyophilized peptides.
- After reconstitution: Refrigerate (approximately 2–8 °C) and follow your institution’s SOPs for aliquoting, handling, and disposal. Avoid repeated freeze–thaw cycles.
- Diluent not included: A suitable laboratory diluent and reconstitution supplies are not provided with this product.
- UV-resistant glass vial to help protect photo-labile peptides during storage.
- Tamper-evident seal to support chain-of-custody and inventory controls.
Why source CJC-1295 DAC from Sports Technology Labs
Quality control across the research-peptide industry is inconsistent, and many suppliers do not publish third-party testing for their products. Independent verification of identity and purity is essential for reproducible research.
Verified by MZ Biolabs (Tucson, AZ), an accredited US laboratory, via HPLC and mass spectrometry, with batch-linked COAs.
Freeze-dried into sterile, UV-resistant glass vials and packaged in the USA.
Supports chain-of-custody, label transparency, and batch-linked traceability.
Transparent business, standard payment methods, no misrepresentation.
What is CJC-1295 DAC?
CJC-1295 DAC is a synthetic long-acting analog of growth hormone-releasing hormone (GHRH), based on a modified GRF(1-29) sequence. Mechanistically, it acts as an agonist at the GHRH receptor, the receptor for endogenous growth hormone-releasing hormone.
The “DAC” denotes a Drug Affinity Complex, a chemical moiety attached to the peptide that binds covalently to circulating serum albumin. This bioconjugation substantially extends the molecule’s plasma half-life relative to unmodified GRF, which is reflected in its multi-day half-life. It is studied as a research chemical to investigate GHRH-receptor signaling in experimental models.
CJC-1295 DAC is an experimental research chemical, supplied strictly for laboratory research. Sports Technology Labs makes no claims regarding its effects, and nothing in this listing should be interpreted as describing outcomes in humans or animals.
Important regulatory information
CJC-1295 DAC is an investigational research peptide. It is not approved by the FDA and is not a drug, food, dietary supplement, or cosmetic. Marketing it for human use is unlawful.
As a growth hormone-releasing hormone (GHRH) analog, CJC-1295 is prohibited by the World Anti-Doping Agency at all times under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), which covers GH-releasing factors and their analogs (ref. 3).
In the United States, CJC-1295 DAC is not a controlled substance and may be legally purchased and possessed for laboratory research use.
Sports Technology Labs are chemical suppliers, not medical providers. We do not condone or encourage consumer use of research compounds.
Scientific references
- Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006;291(6):E1290–E1294.
- National Center for Biotechnology Information. PubChem Compound Summary for CJC-1295 (CAS 863288-34-0): sequence, molecular formula, and molecular weight. PubChem, National Library of Medicine.
- WADA Prohibited List (2025), Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics. WADA.org.
Research use only. All products on this website are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.
